{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:40:23Z","timestamp":1756384823701},"reference-count":15,"publisher":"VM Media SP. zo.o VM Group SK","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5114\/ninp.2012.28265","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T09:40:37Z","timestamp":1347270037000},"page":"189-191","source":"Crossref","is-referenced-by-count":3,"title":["Development of Guillain-Barr\u00e9 syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate"],"prefix":"10.5603","volume":"46","author":[{"given":"Ewa","family":"Motta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Go\u0142ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Hu\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Kazibutowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"key":"10.5114\/ninp.2012.28265_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1468-1331.2000.00041.x","article-title":"Acute axonal form of Guillain-Barr\u00e9 syndrome in a multiple sclerosis patient: chance association or linked disorders","volume":"7","author":"Capello","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.5114\/ninp.2012.28265_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/01.wnl.0000171858.82527.4c","article-title":"Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis","volume":"9","author":"Ekstein","year":"2005","journal-title":"Neurology"},{"key":"10.5114\/ninp.2012.28265_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s004150070118","article-title":"Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate","volume":"247","author":"Frese","year":"2000","journal-title":"J Neurol"},{"key":"10.5114\/ninp.2012.28265_bib4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.37.8.1291","article-title":"Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"37","author":"Mendell","year":"1987","journal-title":"Neurology"},{"key":"10.5114\/ninp.2012.28265_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/01.WNL.0000064163.94122.EB","article-title":"Contrasting effects of IFN-beta and IVIG in children with central and peripheral demyelination","volume":"27","author":"Pirko","year":"2003","journal-title":"Neurology"},{"key":"10.5114\/ninp.2012.28265_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/jnnp.43.11.999","article-title":"Motor unit potential abnormalities in multiple sclerosis: further evidence for a peripheral nervous system defect","volume":"43","author":"Weir","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.5114\/ninp.2012.28265_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s004150050256","article-title":"Acute pure motor neuropathy with antibodies to gangliosides in a patient with multiple sclerosis","volume":"245","author":"Simonetti","year":"1998","journal-title":"J Neurol"},{"key":"10.5114\/ninp.2012.28265_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/CND.0b013e31816f18e3","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis","volume":"9","author":"Sharma","year":"2008","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.5114\/ninp.2012.28265_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.5114\/ninp.2012.28265_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1212\/WNL.58.8_suppl_4.S3","article-title":"Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis","volume":"58","author":"Dhib-Jalbut","year":"2002","journal-title":"Neurology"},{"key":"10.5114\/ninp.2012.28265_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14656566.5.4.875","article-title":"Glatiramer acetate for the treatment of multiple sclerosis","volume":"5","author":"Wolinsky","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.5114\/ninp.2012.28265_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archneur.62.6.889","article-title":"Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy","volume":"62","author":"Allie","year":"2005","journal-title":"Arch Neurol"},{"key":"10.5114\/ninp.2012.28265_bib13","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"},{"key":"10.5114\/ninp.2012.28265_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(01)00250-8","article-title":"Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone","volume":"115","author":"Brenner","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.5114\/ninp.2012.28265_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12016-010-8246-7","article-title":"The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally","volume":"42","author":"Aronovich","year":"2012","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384314603352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384314603352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:35:13Z","timestamp":1546943713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384314603352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["S0028384314603352"],"URL":"https:\/\/doi.org\/10.5114\/ninp.2012.28265","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}